Xarelto Lawsuit Alleges Drug Caused Father’s Death

November 15, 2015 – – BloodThinnerHelp.com reports on a Vermont lawsuit filed against Xarelto manufacturers Bayer AG and Janssen (a subsidiary of Johnson & Johnson). The suit was filed under case number 2:14-cv-00159-CR in the state’s federal court by a young woman who lost her father when he passed away from complications due to uncontrollable bleeding. The complaint filed alleges that blood thinning drug Xarelto caused the man’s uncontrollable bleeding and subsequent death.

The daughter goes on to explain that her father was prescribed Xarelto to treat his atrial fibrillation. Atrial fibrillation is a heart condition which causes the heart to beat more quickly than normal. Although the condition is not a fatal one, it can cause blood clots or strokes, so individuals with atrial fibrillation commonly use blood thinners.

After just a short time taking the medication, the man became injured and was hospitalized. At the hospital, doctors said he had suffered a parenchymal hemorrhage, and they could not stop the bleeding. Because he still had active Xarelto in his system, physicians were unable to make his blood clot. After 6 days of significant blood loss, the man passed away.

The daughter’s complaint goes on to allege that if she or her father were previously aware of this dangerous side effect of Xarelto, they would have never used the drug. She also noted that there were other blood thinners on the market at the time which now appear to be safer alternatives. This is a commonly heard statement. Many Xarelto lawsuit plaintiffs consider the drug to be the most dangerous blood thinner on the market. This is due to the fact that the drug has no corresponding antidote. Manufacturers have been termed negligent and reckless to release it without one.

If someone has Xarelto in their system and they injure themselves and begin to bleed, doctors cannot make their blood clot because of the medication. In these instances, physicians must resort to life-saving measures such as blood transfusions to attempt to keep the patient alive. Those taking traditional blood thinners who are injured and bleeding, however, are able to be given a vitamin K treatment which reverses the effects of the medication and allows their blood to clot.

Because of the recent surge in Xarelto lawsuits, which currently number somewhere around 1,700 federally, they have been consolidated for form multidistrict litigation number 2592. As the cases involved await trial, many expect others to be filed and join. Marc Goldich, Esq. is helping to ensure that anyone who has suffered adverse effects after using Xarelto has the opportunity to look into their legal rights. These people could be entitled to compensation. At this time, Attorney Goldich is offering free consultations to involved individuals.

For additional information on Xarelto bleeding lawsuits or to ask questions, please contact Marc Goldich, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60005393